Nucala
Sanofi/Regeneron on notice as FDA reviews GSK’s Nucala for nasal polyps
Phil Taylor
AstraZeneca, Dupixent, Fasenra, fda, GlaxoSmithKline, inflammatory diseases, nasal polyps, Nucala, Regeneron, Sanofi
0 Comment
GSK eyes nasal polyps use for Nucala after trial success
Richard Staines
AstraZeneca, GlaxoSmithKline, nasal polyps, Nucala, R&D, Sanofi, Teva
0 Comment
News/ News/ Sales and Marketing
Shingrix and Trelegy shield GSK from Advair fallout
Phil Taylor
Advair, financial results, GlaxoSmithKline, Nucala, Shingrix, Trelegy
0 Comment
EU clears GSK’s asthma drug Nucala in patient-friendly format
Phil Taylor
AstraZeneca, Fasenra, GlaxoSmithKline, Nucala, respiratory, severe asthma, Teva
0 Comment